Hostname: page-component-89b8bd64d-sd5qd Total loading time: 0 Render date: 2026-05-10T21:21:08.430Z Has data issue: false hasContentIssue false

Strongyloides stercoralis larvae excretion patterns before and after treatment

Published online by Cambridge University Press:  17 February 2014

F. SCHÄR
Affiliation:
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland University of Basel, Basel, Switzerland
J. HATTENDORF
Affiliation:
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland University of Basel, Basel, Switzerland
V. KHIEU
Affiliation:
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland University of Basel, Basel, Switzerland National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Cambodia
S. MUTH
Affiliation:
National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Cambodia
M. C. CHAR
Affiliation:
National Center for Parasitology, Entomology and Malaria Control, Ministry of Health, Cambodia
H. P. MARTI
Affiliation:
University of Basel, Basel, Switzerland Department of Medical Services and Diagnostics, Swiss Tropical and Public Health Institute, Basel, Switzerland
P. ODERMATT*
Affiliation:
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland University of Basel, Basel, Switzerland
*
* Corresponding author: Swiss Tropical and Public Health Institute, Socinstrasse 57, Postfach 4002 Basel, Switzerland. E-mail: peter.odermatt@unibas.ch

Summary

The variability of larval excretion impedes the parasitological diagnosis of Strongyloides stercoralis in infected individuals. We assessed the number of larvae excreted per gram (LPG) stool in 219 samples from 38 infected individuals over 7 consecutive days before and in 470 samples from 44 persons for 21 consecutive days after ivermectin treatment (200 μg kg−1 BW). The diagnostic sensitivity of a single stool sample was about 75% for individuals with low-intensity infections (⩽1 LPG) and increased to 95% for those with high-intensity infections (⩾10 LPG). Doubling the number of samples examined per person increased sensitivity to more than 95%, even for low-intensity infections. There was no indication of a cyclic excretion of larvae. After treatment, all individuals stopped excreting larvae within 3 days. Larvae were not detected during any of the following 18 days (total 388 Baermann and 388 Koga Agar tests). Two stool samples, collected on consecutive days, are recommended in settings where low or heterogeneous infection intensities are likely. In this way, taking into account the possible biological variability in excretion, the efficacy of ivermectin treatment can be assessed as soon as 4 days after treatment.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable